Kinase, in vitro: An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.
BRD4	S1616-p
CDK7	S1619-p
mTOR	S1934-p

Putative in vivo kinases: An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.
CDK1	S1616-p , S1619-p
CDK7	S1619-p
CK2A1	S1616-p , S1619-p

Regulatory protein:
CCNH	S1616-p , S1619-p
CDK9	S1616-p
DDB1	S1619-p
HBD	S1619-p
HEXIM1	S1616-p , S1619-p
Ikaros	S1616-p
RIPK3	T1817-p , T1819-p

Treatment:
alvocidib	S1616-p , S1619-p
anisomycin	S1619-p
bacterial infection	S1619-p
DNA_binding	S1619-p
fertilization	S1616-p , S1619-p
H-89	S1619-p
IFN-beta	S1619-p
IFN-gamma	Y1874-p , T1885-p
insulin	S1878-p , S1913-p , S1920-p , S1927-p , S1934-p
ischemia	S1616-p , S1619-p
ischemia/reperfusion	S1616-p , S1619-p
LY294002	S1878-p , S1913-p , S1920-p , S1927-p , S1934-p
NM-PP1	S1616-p , S1619-p
siRNA	K1859-ub , K1866-ub , K1873-ub , K1887-ub , K1908-ub , K1922-ub
tamoxifen	S1619-p
Torin1	S1920-p , S1934-p
trichostatin_A	S1619-p
UV	S1616-p , S1619-p